Search Results - "Haklai, Ronit"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1
  2. 2

    Downregulation of survivin and aurora A by histone deacetylase and RAS inhibitors: A new drug combination for cancer therapy by Biran, Anat, Brownstein, Michael, Haklai, Ronit, Kloog, Yoel

    Published in International journal of cancer (01-02-2011)
    “…Histone deacetylase (HDAC) inhibitors, such as valproic acid (VPA), constitute a novel class of anticancer agents that cause an increase in acetylated histones…”
    Get full text
    Journal Article
  3. 3

    Galectin-3/MAC-2, Ras and PI3K activate complement receptor-3 and scavenger receptor-AI/II mediated myelin phagocytosis in microglia by Rotshenker, Shlomo, Reichert, Fanny, Gitik, Miri, Haklai, Ronit, Elad-Sfadia, Galit, Kloog, Yoel

    Published in Glia (15-11-2008)
    “…The removal of degenerated myelin is essential for repair in Wallerian degeneration that follows traumatic injury to axons and in autoimmune demyelinating…”
    Get full text
    Journal Article
  4. 4

    Suppression of lung cancer tumor growth in a nude mouse model by the Ras inhibitor salirasib (farnesylthiosalicylic acid) by Zundelevich, Adi, Elad-Sfadia, Galit, Haklai, Ronit, Kloog, Yoel

    Published in Molecular cancer therapeutics (01-06-2007)
    “…Aberrant Ras pathway functions contribute to the malignant phenotype of lung cancers. Inhibitors of Ras might therefore be considered as potential drugs for…”
    Get full text
    Journal Article
  5. 5

    Disruption of Cooperation Between Ras and MycN in Human Neuroblastoma Cells Promotes Growth Arrest by YAARI, Shira, JACOB-HIRSCH, Jasmine, AMARIGLIO, Ninette, HAKLAI, Ronit, RECHAVI, Gideon, KLOOG, Yoel

    Published in Clinical cancer research (15-06-2005)
    “…Purpose: Our aim was to examine whether active Ras and MycN cooperation contributes to the malignant phenotype of human neuroblastoma with amplified MycN gene,…”
    Get full text
    Journal Article
  6. 6

    The Ras Inhibitor S-trans,trans-Farnesylthiosalicylic Acid Chemosensitizes Human Tumor Cells Without Causing Resistance by Gana-Weisz, Mali, Halaschek-Wiener, Julius, Jansen, Burkhard, Elad, Galit, Haklai, Ronit, Kloog, Yoel

    Published in Clinical cancer research (01-02-2002)
    “…Ras transformation requires Ras membrane anchorage, which is promoted by a farnesylcysteine carboxymethyl ester and by additional sequences specific to each…”
    Get full text
    Journal Article
  7. 7

    The association between let-7, RAS and HIF-1α in Ewing Sarcoma tumor growth by Hameiri-Grossman, Michal, Porat-Klein, Adi, Yaniv, Isaac, Ash, Shifra, Cohen, Ian J, Kodman, Yona, Haklai, Ronit, Elad-Sfadia, Galit, Kloog, Yoel, Chepurko, Elena, Feinmesser, Meora, Issakov, Josephine, Sher, Osnat, Luria, Drorit, Kollender, Yehuda, Weizman, Avraham, Avigad, Smadar

    Published in Oncotarget (20-10-2015)
    “…Ewing Sarcoma (ES) is the second most common primary malignant bone tumor in children and adolescents. microRNAs (miRNAs) are involved in cancer as tumor…”
    Get full text
    Journal Article
  8. 8

    Abstract A76: Ras pathway and HIF-1α contribute to the aggressiveness of Ewing sarcoma by Hameiri-Grossman, Michal, Porat-Klein, Adi, Cohen, Ian J., Ash, Shifra, Kloog, Yoel, Haklai, Ronit, Elad-Sfadia, Galit, Weizman, Avraham, Yaniv, Isaac, Avigad, Smadar

    Published in Cancer research (Chicago, Ill.) (15-10-2014)
    “…Aim: Ewing sarcoma (ES) is the second most common and aggressive primary malignant bone tumor in children and adolescents. The hallmarks of the tumor are…”
    Get full text
    Journal Article
  9. 9

    Ras inhibition attenuates myocardial ischemia–reperfusion injury by Pando, Rakefet, Cheporko, Yelena, Haklai, Ronit, Maysel-Auslender, Sofia, Keren, Gad, George, Jacob, Porat, Eyal, Sagie, Alex, Kloog, Yoel, Hochhauser, Edith

    Published in Biochemical pharmacology (15-05-2009)
    “…Hemodynamic and histological staining of hearts treated pre- and post-LAD ligation with FTS showed better function and a reduction in the area of irreversible…”
    Get full text
    Journal Article
  10. 10

    The Ras antagonist farnesylthiosalicylic acid ameliorates experimental myocarditis in the rat by Pando, Rakefet, Barshack, Iris, Raz, Alon, Luboshits, Galia, Haklai, Ronit, Maysel-Auslender, Sofia, Kloog, Yoel, Keren, Gad, George, Jacob

    Published in Cardiovascular pathology (01-03-2010)
    “…Abstract Background Myocarditis is an inflammatory disorder of the heart in which T lymphocytes have a central role. No effective treatment is currently at…”
    Get full text
    Journal Article